| Lineage |
Neural Crest > Autonomic Nervous System |
| Markers |
PGP9.5, HuC/D, VAChT, nNOS, CGRP, NF200 |
| Brain Regions |
Pancreatic Islets - Intrapancreatic Plexus |
| Disease Relevance |
Type 2 Diabetes, Pancreatitis, Pancreatic Cancer |
Pancreatic Plexus Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Pancreatic plexus neurons are autonomic nerve cells located within the pancreatic islets (islets of Langerhans) and surrounding exocrine tissue. These neurons form the intrinsic innervation of the pancreas and regulate hormone secretion (insulin, glucagon, somatostatin), exocrine secretion, and blood flow. The pancreatic plexus represents a crucial interface between the autonomic nervous system and endocrine function[^1].
- Located within pancreatic islets
- Closely associated with beta, alpha, and delta cells
- Dense innervation of islet vasculature
- Parasympathetic: Via vagus nerve (cranial nerve X)
- Sympathetic: From celiac ganglion
- Sensory: Via spinal afferents (T6-T10)
- Function: Stimulate insulin and glucagon secretion
- Neurotransmitter: Acetylcholine
- Receptors: Muscarinic (M3) on islet cells
- Function: Inhibit hormone secretion
- Neurotransmitter: Norepinephrine
- Receptors: Alpha-2 adrenergic (inhibitory)
- Function: Monitor pancreatic status
- Neurotransmitters: CGRP, Substance P
- Properties: Polymodal nociceptors
- Function: Modulate blood flow
- Neurotransmitter: Nitric oxide
- Co-transmitters: VIP
- Effect on beta cells: Increased insulin secretion
- Effect on alpha cells: Increased glucagon secretion
- Mechanism: Muscarinic receptor activation, increased intracellular calcium
- Physiological trigger: Cephalic phase of digestion, meal anticipation
- Effect on beta cells: Decreased insulin secretion
- Effect on alpha cells: Increased glucagon secretion
- Effect on delta cells: Decreased somatostatin
- Physiological trigger: Stress, exercise, fasting
- Glucose sensing: Neurons detect blood glucose changes
- Feedback loops: Hormones modulate neural activity
- CNS integration: Hypothalamic-pancreatic connections
- Autoimmune destruction of beta cells
- Loss of cholinergic stimulation
- Neural dysfunction precedes hyperglycemia
- Islet neuropathy observed
- Reduced neural density in islets
- Autonomic dysfunction contributes to insulin resistance[^2]
- Altered neurotransmitter release
- Impaired glucose sensing
- Inflammation via sensory neurons
- Neural activation in pain pathways
- Sensitization of pancreatic afferents
- Changes in pancreatic plexus morphology
- Perineural invasion common
- Neural remodeling
- Pain management challenges[^3]
- Spontaneous activity modulated by glucose
- Synaptic inputs from vagus nerve
- Gap junction coupling between neurons
- Activity Patterns: Bursting, tonic firing
- Muscarinic agonists (beta-cell function)
- GABAnergic modulation
- Vagal stimulation therapy
- Neural blockades for pain
- Incretin-based therapies (GLP-1)
- Vagal tone enhancement
- Autonomic nervous system modulation
The study of Pancreatic Plexus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Ahrén, Autonomic regulation of islet hormone secretion (2019)
- Karlsson et al., Islet neuropathy in type 2 diabetes (2018)
- Bapat & Singh, Neural invasion in pancreatic cancer (2019)
- K、教 et al., Pancreatic innervation and diabetes (2020)
- Lindfors et al., Neural control of the pancreas (2017)